The CEVR and SCOPE Health Inc. sign MoU to develop and commercialize new treatments for dry eye and ocular surface conditions.
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement
